Brenda Hefti compensation by year
EXELIXIS Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $454,545 |
| Bonus | $0 |
| Stock awards | $3,451,975 |
| Option awards | $0 |
| Non-equity incentive | $286,751 |
| Pension and deferred compensation | $0 |
| All other | $11,000 |
| Total | $4,204,271 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: EXELIXIS, INC. DEF 14A filed April 15, 2026, accession 0000939767-26-000046, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 34,533 | $1,504,948 | — |
| RSU | 30,170 | $1,314,809 | — |
| RSU | 14,789 | $644,505 | — |
| RSU | 14,774 | $643,851 | — |
| RSU | 14,272 | $621,974 | — |
| RSU | 10,704 | $466,480 | — |
| RSU | 7,386 | $321,882 | — |
| RSU | 5,775 | $251,675 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in EXELIXIS, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
2 Form 4 lines since the FY2025 proxy (filed April 15, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-18 | Sale | 10b5-1 | 6,625 | $50.21 | 106,762 |
| 2026-05-15 | Tax withholding | 10b5-1 | 6,411 | $51.10 | 113,387 |
The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
EXELIXIS’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michael Morrissey | President and Chief Executive Officer | $33,239,183 |
| Amy Peterson | Former Executive Vice President, Product Development and Medical Affairs and Chief Medical Officer | $11,146,034 |
| Christopher Senner | Executive Vice President and Chief Financial Officer | $10,648,472 |
| Dana Aftab | Executive Vice President, Research and Development | $10,547,248 |
| Patrick Haley | Executive Vice President, Commercial | $9,021,416 |
| Jeffrey Hessekiel | Former Executive Vice President and General Counsel | $8,992,592 |
| Brenda Hefti · this page | Senior Vice President and General Counsel | $4,204,271 |
The full EXELIXIS compensation record
free company briefThis page is one person within EXELIXIS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order EXELIXIS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are EXELIXIS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat